Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBV NYSE:IBM NYSE:O On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$214.86+1.2%$208.95$180.25▼$244.81$375.09B0.326.47 million shs3.81 million shsIBMInternational Business Machines$253.14+12.5%$238.60$212.34▼$324.90$211.47B0.586.91 million shs25.37 million shsORealty Income$62.220.0%$62.76$54.64▼$67.93$58.04B0.755.62 million shs3.81 million shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+1.10%+1.85%+4.83%-4.48%+18.22%IBMInternational Business Machines+12.65%+15.90%-1.17%-1.58%-3.10%ORealty Income+0.01%+0.45%-2.93%-5.87%+12.54%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$214.86+1.2%$208.95$180.25▼$244.81$375.09B0.326.47 million shs3.81 million shsIBMInternational Business Machines$253.14+12.5%$238.60$212.34▼$324.90$211.47B0.586.91 million shs25.37 million shsORealty Income$62.220.0%$62.76$54.64▼$67.93$58.04B0.755.62 million shs3.81 million shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+1.10%+1.85%+4.83%-4.48%+18.22%IBMInternational Business Machines+12.65%+15.90%-1.17%-1.58%-3.10%ORealty Income+0.01%+0.45%-2.93%-5.87%+12.54%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.88Moderate Buy$253.4317.95% UpsideIBMInternational Business Machines 2.70Moderate Buy$294.4116.31% UpsideORealty Income 2.47Hold$67.358.24% UpsideCurrent Analyst Ratings BreakdownLatest ABBV, IBM, and O Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/21/2026IBMInternational Business Machines WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform5/15/2026ABBVAbbVie EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$235.005/14/2026ABBVAbbVie Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$294.00 ➝ $298.005/13/2026ORealty Income MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$68.00 ➝ $66.005/12/2026ORealty Income ScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform5/12/2026ORealty Income ScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Outperform$69.00 ➝ $72.005/11/2026ORealty Income Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/7/2026ORealty Income Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$70.00 ➝ $71.005/6/2026IBMInternational Business Machines Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$330.00 ➝ $300.005/6/2026IBMInternational Business Machines WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$320.005/4/2026IBMInternational Business Machines Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$61.16B6.21$15.32 per share14.02($3.74) per share-57.45IBMInternational Business Machines$67.54B3.52$19.28 per share13.13$35.17 per share7.20ORealty Income$5.75B10.09$3.97 per share15.69$44.22 per share1.41Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.23B$2.03105.8413.180.735.79%-576.45%13.39%7/30/2026 (Estimated)IBMInternational Business Machines$10.59B$11.3122.3818.952.3315.61%37.23%7.49%7/22/2026 (Estimated)ORealty Income$1.06B$1.2251.0013.554.8718.94%2.80%1.55%8/5/2026 (Estimated)Latest ABBV, IBM, and O EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2026Q1 2026ORealty Income$1.10$1.13+$0.03$0.33$1.39 billion$1.55 billion4/29/2026Q1 2026ABBVAbbVie$2.59$2.65+$0.06$0.39$14.72 billion$15.00 billion4/22/2026Q1 2026IBMInternational Business Machines$1.81$1.91+$0.10$1.28$15.60 billion$15.92 billion2/24/2026Q4 2025ORealty Income$1.08$1.08N/A$0.32$1.40 billion$1.40 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.923.22%+6.80%340.89%53 YearsIBMInternational Business Machines$6.762.67%+0.61%59.77%30 YearsORealty Income$3.255.22%+4.50%266.39%1 YearsLatest ABBV, IBM, and O DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2026ORealty Incomemonthly$0.27055.24%5/29/20265/29/20266/15/20264/22/2026IBMInternational Business Machinesquarterly$1.692.95%5/8/20265/8/20266/10/20264/14/2026ORealty Incomemonthly$0.27055.05%4/30/20264/30/20265/15/20263/11/2026ORealty Incomemonthly$0.27055.31%3/31/20263/31/20264/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVieN/A0.800.68IBMInternational Business Machines1.750.800.76ORealty Income0.721.561.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%IBMInternational Business Machines58.96%ORealty Income70.81%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.06%IBMInternational Business Machines0.27%ORealty Income0.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie57,0001.77 billion1.77 billionOptionableIBMInternational Business Machines286,800939.89 million937.35 millionOptionableORealty Income400932.49 million931.56 millionOptionableABBV, IBM, and O HeadlinesRecent News About These CompaniesGot $500? The Best Dividend Stocks to Buy Right NowMay 21 at 2:58 PM | fool.comGot $500? The Best Dividend Stocks to Buy Right NowMay 21 at 1:51 PM | fool.comHandelsbanken Fonder AB Reduces Stock Position in Realty Income Corporation $OMay 21 at 5:14 AM | marketbeat.comAew Capital Management L P Cuts Stock Position in Realty Income Corporation $OMay 21 at 3:35 AM | marketbeat.comABN Amro Investment Solutions Has $61.65 Million Stock Position in Realty Income Corporation $OMay 21 at 3:18 AM | marketbeat.comRealty Income Raises Its Investment Bar: Does $9.5B Show Confidence?May 20 at 12:01 PM | zacks.comRealty Income's valuation looks too cheap for its quality, investor saysMay 20 at 8:50 AM | seekingalpha.comHow Much Do You Really Need Invested to Replace a $50,000 Salary If Half Your Income Comes From REITs?May 20 at 6:57 AM | 247wallst.comThis More Than 5%-Yielding Stock Just Declared Its 671st Consecutive Monthly Dividend. Here's Why It's a Must Buy for Passive Income.May 20 at 6:31 AM | fool.comResona Asset Management Co. Ltd. Sells 20,958 Shares of Realty Income Corporation $OMay 20 at 5:24 AM | marketbeat.comNorth Dakota State Investment Board Acquires Shares of 31,008 Realty Income Corporation $OMay 20 at 4:57 AM | marketbeat.com2 Dividend Stocks to Buy and Hold ForeverMay 19 at 10:58 PM | fool.comWes Moss’ $1.6 Million Portfolio Rule Quietly Beats Government Pensions for Affluent RetireesMay 19 at 5:57 PM | 247wallst.comHere is What to Know Beyond Why Realty Income Corporation (O) is a Trending StockMay 19 at 12:57 PM | finance.yahoo.com5 High-Yield Dividend Stocks (VZ, O, MO) Delivering Over 5% Returns in 2026May 19 at 11:11 AM | blockonomi.comHere is What to Know Beyond Why Realty Income Corporation (O) is a Trending StockMay 19 at 10:01 AM | zacks.comProShare Advisors LLC Reduces Position in Realty Income Corporation $OMay 19 at 6:18 AM | marketbeat.comVerizon and 4 Other Stocks With 5% Yields—and Market-Beating ReturnsMay 18, 2026 | finance.yahoo.comRealty Income Corporation $O Shares Sold by WealthPlan Investment Management LLCMay 17, 2026 | marketbeat.comDNB Asset Management AS Has $18.23 Million Stake in Realty Income Corporation $OMay 17, 2026 | marketbeat.comAssessing Realty Income (O) Valuation After Strong Q1, Higher AFFO Guidance And Ongoing Monthly DividendsMay 16, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?By Thomas Hughes | April 29, 2026Microsoft Earnings Look Strong, But Investors Focus on RisksBy Chris Markoch | April 30, 2026These 3 AI Stocks Just Crushed Earnings: Still Time To Buy?By Dan Schmidt | May 2, 2026Catching Falling Knives: Is It Time to Buy These Beaten-Down Stocks?By Dan Schmidt | May 11, 2026Texas Instruments Surges 18% as Data Center Demand Spikes 90%By Thomas Hughes | April 24, 2026ABBV, IBM, and O Company DescriptionsAbbVie NYSE:ABBV$214.86 +2.56 (+1.20%) Closing price 05/21/2026 03:59 PM EasternExtended Trading$214.00 -0.85 (-0.40%) As of 04:47 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.International Business Machines NYSE:IBM$253.14 +28.14 (+12.50%) Closing price 05/21/2026 03:59 PM EasternExtended Trading$259.53 +6.39 (+2.53%) As of 04:57 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.Realty Income NYSE:O$62.22 -0.02 (-0.04%) Closing price 05/21/2026 03:59 PM EasternExtended Trading$62.30 +0.08 (+0.13%) As of 04:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 644 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 123 times since Realty Income's public listing in 1994 (NYSE: O). More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
